128 related articles for article (PubMed ID: 22377517)
1. Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists.
Guo C; Pairish M; Linton A; Kephart S; Ornelas M; Nagata A; Burke B; Dong L; Engebretsen J; Fanjul AN
Bioorg Med Chem Lett; 2012 Apr; 22(7):2572-8. PubMed ID: 22377517
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists.
Yamamoto S; Matsunaga N; Hitaka T; Yamada M; Hara T; Miyazaki J; Santou T; Kusaka M; Yamaoka M; Kanzaki N; Furuya S; Tasaka A; Hamamura K; Ito M
Bioorg Med Chem; 2012 Jan; 20(1):422-34. PubMed ID: 22094279
[TBL] [Abstract][Full Text] [Related]
3. Learning from estrogen receptor antagonism: structure-based identification of novel antiandrogens effective against multiple clinically relevant androgen receptor mutants.
Liu B; Geng G; Lin R; Ren C; Wu JH
Chem Biol Drug Des; 2012 Mar; 79(3):300-12. PubMed ID: 22151347
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel androgen receptor antagonists via molecular modeling.
Zhao C; Choi YH; Khadka DB; Jin Y; Lee KY; Cho WJ
Bioorg Med Chem; 2016 Feb; 24(4):789-801. PubMed ID: 26780832
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
Inoue K; Urushibara K; Kanai M; Yura K; Fujii S; Ishigami-Yuasa M; Hashimoto Y; Mori S; Kawachi E; Matsumura M; Hirano T; Kagechika H; Tanatani A
Eur J Med Chem; 2015 Sep; 102():310-9. PubMed ID: 26295173
[TBL] [Abstract][Full Text] [Related]
6. 20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth.
Fousteris MA; Schubert U; Roell D; Roediger J; Bailis N; Nikolaropoulos SS; Baniahmad A; Giannis A
Bioorg Med Chem; 2010 Oct; 18(19):6960-9. PubMed ID: 20826091
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists.
Yamamoto S; Tomita N; Suzuki Y; Suzaki T; Kaku T; Hara T; Yamaoka M; Kanzaki N; Hasuoka A; Baba A; Ito M
Bioorg Med Chem; 2012 Apr; 20(7):2338-52. PubMed ID: 22391033
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel 5-methyl-1H-pyrazole derivatives as potential antiprostate cancer agents: Design, synthesis, molecular modeling, and biological evaluation.
Zhang D; Asnake S; Zhang J; Olsson PE; Zhao G
Chem Biol Drug Des; 2018 Jun; 91(6):1113-1124. PubMed ID: 29388326
[TBL] [Abstract][Full Text] [Related]
9. Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.
Duke CB; Jones A; Bohl CE; Dalton JT; Miller DD
J Med Chem; 2011 Jun; 54(11):3973-6. PubMed ID: 21506597
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.
Ohta K; Goto T; Fujii S; Kawahata M; Oda A; Ohta S; Yamaguchi K; Hirono S; Endo Y
Bioorg Med Chem; 2011 Jun; 19(11):3540-8. PubMed ID: 21536446
[TBL] [Abstract][Full Text] [Related]
11. Multivalent peptidomimetic conjugates: a versatile platform for modulating androgen receptor activity.
Levine PM; Imberg K; Garabedian MJ; Kirshenbaum K
J Am Chem Soc; 2012 Apr; 134(16):6912-5. PubMed ID: 22509763
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist.
Andavar S; Vaithilingam M; Selvaraj D; Kumaran AA; Devanathan K
Anticancer Agents Med Chem; 2020; 20(1):84-93. PubMed ID: 31755396
[TBL] [Abstract][Full Text] [Related]
13. Modeling androgen receptor flexibility: a binding mode hypothesis of CYP17 inhibitors/antiandrogens for prostate cancer therapy.
Gianti E; Zauhar RJ
J Chem Inf Model; 2012 Oct; 52(10):2670-83. PubMed ID: 22924551
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
Chen H; Yu YZ; Tian XM; Wang CL; Qian YN; Deng ZA; Zhang JX; Lv DJ; Zhang HB; Shen JL; Yuan M; Zhao SC
Bioorg Med Chem; 2019 Jan; 27(1):133-143. PubMed ID: 30482547
[TBL] [Abstract][Full Text] [Related]
15. Discovery of non-LBD inhibitor for androgen receptor by structure-guide design.
Ryu BJ; Kim N; Kim JT; Koo TS; Yoo SE; Jeong SH; Kim SH; Kang NS
Bioorg Med Chem Lett; 2013 Jul; 23(13):3887-90. PubMed ID: 23727044
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer.
Guo C; Kephart S; Ornelas M; Gonzalez J; Linton A; Pairish M; Nagata A; Greasley S; Elleraas J; Hosea N; Engebretsen J; Fanjul AN
Bioorg Med Chem Lett; 2012 Jan; 22(2):1230-6. PubMed ID: 22197140
[TBL] [Abstract][Full Text] [Related]
17. SAR based design of nicotinamides as a novel class of androgen receptor antagonists for prostate cancer.
Yang SH; Song CH; Van HT; Park E; Khadka DB; Gong EY; Lee K; Cho WJ
J Med Chem; 2013 Apr; 56(8):3414-8. PubMed ID: 23527816
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of second-generation tropanol-based androgen receptor modulators.
Sundén H; Holland MC; Poutiainen PK; Jääskeläinen T; Pulkkinen JT; Palvimo JJ; Olsson R
J Med Chem; 2015 Feb; 58(3):1569-74. PubMed ID: 25646649
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists.
Xiao HY; Balog A; Attar RM; Fairfax D; Fleming LB; Holst CL; Martin GS; Rossiter LM; Chen J; Cvjic ME; Dell-John J; Geng J; Gottardis MM; Han WC; Nation A; Obermeier M; Rizzo CA; Schweizer L; Spires T; Shan W; Gavai A; Salvati ME; Vite G
Bioorg Med Chem Lett; 2010 Aug; 20(15):4491-5. PubMed ID: 20584610
[TBL] [Abstract][Full Text] [Related]
20. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
Zhang X; Li X; Allan GF; Musto A; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2006 Jun; 16(12):3233-7. PubMed ID: 16603353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
